Clinical trials in Parkinsons disease patients treated with the GLP-1 agonist exenatide showed improvements in motor and cognitive symptoms compared to placebo groups
The company has a policy requiring advertisers to get written permission and provide evidence of an appropriate license before they can promote prescription drugs, and only online pharmacies, telehealth providers and drugmakers are eligible
When starting a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Zepbound, you begin at a very low dose
Prusogliptin , developed by CSPC Ouyi Pharmaceutical, is a novel oral dipeptidyl peptidase-4 (DPP-4) inhibitor that was approved by National Medical Products Administration (NMPA) on January 8, 2025
Protein also steadies blood sugar, which can help prevent nausea that comes from sugar fluctuations